(Q37719861)

22 August 2017

1 reference

title

Diagnosis of bone metastases in urological malignancies--an update (English)

1 reference

22 August 2017

0 references

Nieroshan Rajarubendra

series ordinal

1

1 reference

22 August 2017

Damien Bolton

series ordinal

2

1 reference

22 August 2017

Nathan Lawrentschuk

series ordinal

3

1 reference

22 August 2017

language of work or name

English

0 references

publication date

25 March 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

76

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

782-790

1 reference

Mechanisms of bone metastasis

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Metastases in carcinoma; analysis of 1000 autopsied cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

7 January 2021

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Metastasis to bone: causes, consequences and therapeutic opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

The management of metastatic bone disease with the combination of bisphosphonates and radiotherapy: from theory to clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Markers of bone turnover in bone metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Incidence of hypercalcemia in patients with malignancy referred to a comprehensive cancer center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

7 January 2021

Hypercalcaemia in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Bone imaging in metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: current practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

7 January 2021

MRI of bone metastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Whole-Body MRI for Metastases Screening: A Preliminary Study Using 3D VIBE Sequences With Automatic Subtraction Between Noncontrast and Contrast Enhanced Images

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

The hazards of the biopsy, revisited. Members of the Musculoskeletal Tumor Society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

State-of-the-art approaches to detecting early bone metastasis in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Baseline staging of newly diagnosed prostate cancer: a summary of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Imaging of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Positron emission tomography for prostate, bladder, and renal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Diagnosis and monitoring of urological tumors using positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Eastern Cooperative Oncology Group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Association of radionuclide bone scan and serum alkaline phosphatase in patients with metastatic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas - a preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Whole-body F-18 sodium fluoride PET-CT in a patient with renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

New imaging modalities in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Bladder cancer: the value of routine bone scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Clinical significance of routine pre-cystectomy bone scans in patients with muscle-invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Cost-effective analysis of pre-cystectomy radioisotope scans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Radiologic diagnosis and staging of renal and bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

Recent developments in urologic oncology: positron emission tomography molecular imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2009.12.050

10.1016/J.UROLOGY.2009.12.050

7 January 2021

Identifiers

DOI

1 reference

22 August 2017

1 reference